ArticleArchives of medical science : AMS2026
Shikonin treatment ameliorates lipopolysaccharide-induced acute liver failure in mice via regulating miR-106/MCL1 and miR-34a/SIRT1/TP53 signaling.
Fan Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.